Søren Tulstrup

Søren Tulstrup currently works at Shire Human Genetic Therapies, Inc., as Senior Vice President from 2012.
Mr. Tulstrup also formerly worked at Vifor Pharma AG, as Chief Executive Officer from 2014 to 2016, Roche Innovation Center Copenhagen A, as President & Chief Executive Officer from 2008 to 2012, Vifor Pharma Management AG, as Chief Executive Officer, Hansa Biopharma AB, as President & Chief Executive Officer from 2018 to 2025, Organon Pharma (UK) Ltd., as Managing Director-Denmark, Abbott Laboratories, as Principal, Merck & Co., Inc., as Vice President-Global Human Health, Sandoz, Inc., as Principal, Novartis AG, as Deputy Regional Manager, and Shire Pharmaceuticals, Inc., as Senior Vice President from 2012 to 2014.
Mr. Tulstrup received his graduate degree from Northwestern University and undergraduate degree and graduate degree from Copenhagen Business School.